Zarxio (Filgrastim-sndz): The First Biosimilar Approved by the FDA. [electronic resource]
Publication details: P & T : a peer-reviewed journal for formulary management Jan 2017Description: 19-23 p. digitalISSN:- 1052-1372
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.